Opioid users sought SR-17018 to ease withdrawal until the DEA banned it
🤖 AI-generated content — The title and summary were produced automatically by artificial intelligence, without human editorial review.
Laura Bohn's NIDA-funded team reported in Cell in 2017 that SR-17018 relieved pain in mice without respiratory depression and helped morphine-dependent mice reset tolerance without withdrawal. Users on Reddit and Discord credited it for quitting opioids while it remained unregulated and sold online; Bohn was pursuing human trials. The DEA then scheduled it in the same category as heroin, halting that path despite its research promise.
Continue in the app — vote & join in ➔Source: Wired · via ahirlevel.hu